Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
StimuSIL, Inc. See All Filings	D	2025-03-07 14:26:45 UTC
Amount To Be Raised $599,988 Associated Brokers / Dealers N/A CIK Number 0001939123 Filed Document 0001939123-25-000002 Exclusions or Exemptions 506b Accepted Date 2025-03-07 14:26:45 UTC Type of Offering D Industry Biotechnology Principal Place of Business DELAWARE Revenue or Assets Decline to Disclose Type of Security Equity
StimuSIL, Inc. See All Filings	D	2024-05-10 16:41:26 UTC
Amount To Be Raised $1,103,787 Associated Brokers / Dealers N/A CIK Number 0001939123 Filed Document 0001939123-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-05-10 16:41:26 UTC Type of Offering D Industry Biotechnology Principal Place of Business DELAWARE Revenue or Assets Decline to Disclose Type of Security Equity
StimuSIL, Inc. See All Filings	D	2023-09-12 17:50:03 UTC
Amount To Be Raised $48,799 Associated Brokers / Dealers N/A CIK Number 0001939123 Filed Document 0001939123-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-09-12 17:50:03 UTC Type of Offering D Industry Biotechnology Principal Place of Business DELAWARE Revenue or Assets Decline to Disclose Type of Security Equity
StimuSIL, Inc. See All Filings	D/A	2022-08-30 17:16:24 UTC
Amount To Be Raised $574,998 Associated Brokers / Dealers N/A CIK Number 0001939123 Filed Document 0001939123-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-08-30 17:16:24 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business DELAWARE Revenue or Assets Decline to Disclose Type of Security Equity
StimuSIL, Inc. See All Filings	D	2022-08-12 14:51:27 UTC
Amount To Be Raised $569,734 Associated Brokers / Dealers N/A CIK Number 0001939123 Filed Document 0001939123-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-08-12 14:51:27 UTC Type of Offering D Industry Biotechnology Principal Place of Business DELAWARE Revenue or Assets Decline to Disclose Type of Security Equity